Companies: 10,795·Total market cap: $144.5T
Applied Therapeutics, Inc.

Applied Therapeutics, Inc.

APLTNASDAQHealthcare
$0.10
+$0.00(+0.00%)
Market Cap$14862969
P/E Ratio—
52W High$1.5
52W Low$0.09
SEC Filings

Applied Therapeutics, Inc. (APLT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001697532 · APLT · NASDAQ · as of Jun 8, 2026

Filing snapshot

529
Total Filings
SCHEDULE 13G/A
Latest Form
2026-02-17
Most Recent
2019
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001697532 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-04-15
Fiscal Year End
Apr 15, 2025
Accession No.
0000950170-25-053840
Primary Document
aplt-20241231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001697532 · Accession 0000950170-25-053840

Latest Key Filings

10-QQuarterly Report
10-Q
2025-11-13
View 10-Q on SEC
8-KCurrent Report
8-K
2026-02-03Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
15-12G15-12G
15-12G
2026-02-13
View
EFFECTEFFECT
EFFECT
2026-02-06
View
EFFECTEFFECT
EFFECT
2026-02-06
View
POS AMPOS AM
POS AM
2026-02-03
View
POS AMPOS AM
POS AM
2026-02-03
View
S-8 POSS-8 POS
S-8 POS
2026-02-03
View
S-8 POSS-8 POS
S-8 POS
2026-02-03
View
S-8 POSS-8 POS
S-8 POS
2026-02-03
View
S-8 POSS-8 POS
S-8 POS
2026-02-03
View
25-NSE25-NSE
25-NSE
2026-02-03
View
8-KCurrent Report
8-K
2026-02-03
View
SC 14D9/ASC 14D9/A
SC 14D9/A
2026-02-03
View
SC TO-T/ASC TO-T/A
SC TO-T/A
2026-02-03
View
SC 14D9/ASC 14D9/A
SC 14D9/A
2026-01-30
View
Showing 1–15 of 336 filingsForm 4 / 144 hidden· 529 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001697532  |  Exchange: NASDAQ · Healthcare

Applied Therapeutics, Inc. (NASDAQ: APLT) has submitted 529 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001697532, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Applied Therapeutics, Inc.'s most comprehensive regulatory disclosure. The most recent Applied Therapeutics, Inc. 10-K was filed on 2025-04-15 for fiscal year ending 2025. Historical APLT 10-K annual reports are available from 2017 through 2025.

Investors researching Applied Therapeutics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
ELTX SEC Filings →FBRX SEC Filings →NKTX SEC Filings →MOLN SEC Filings →MIST SEC Filings →CRDF SEC Filings →PEPG SEC Filings →CRBP SEC Filings →
→ APLT Financials→ APLT Earnings→ APLT Insider Trades

Frequently Asked Questions

APLT SEC Filings · 8 questions

Applied Therapeutics, Inc. (APLT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 529 filings and access original documents at no cost. Applied Therapeutics, Inc.'s CIK is 0001697532.

APLT SEC filingsApplied Therapeutics, Inc. SEC documentsfind APLT 10-K